This Board consists of experts in the fields of oncology, pharmacology, natural products, drug discovery and development, traditional Chinese medicine, acupuncture, and homeopathy. The Board also contains representatives from the cancer patient community. This Editorial Board meets quarterly to write and update information summaries on complementary and alternative therapies for cancer.
- Jeffrey White, M.D., Editor-in-Chief
National Cancer Institute Rockville, MD - Donald I. Abrams, M.D.
UCSF Osher Center for Integrative Medicine San Francisco, CA - Lawrence Berk, M.D., Ph.D.
University of South Florida Tampa FL - John A. Beutler, Ph.D.
National Cancer Institute Frederick, MD - Keith Block, M.D.
Block Center for Integrative Cancer Treatment Skokie, IL - John Boik Ph.D.
New Earth Biomed Irvine, CA - Gordon M. Cragg, Ph.D.
Bethesda, MD - Jinhui Dou, Ph.D.
Food and Drug Administration Rockville, MD - Wayne B. Jonas, M.D.
Samueli Institute Alexandria, VA - Kara Kelly, M.D.
Columbia University New York, NY
| - Douglas Kinghorn, Ph.D., D.Sc.
Ohio State University Columbus, OH - Nagi B. Kumar, Ph.D., R.D., FADA
Moffitt Cancer Center Tampa, FL - Elena J. Ladas, M.S., R.D.
Columbia University New York, NY - Neal Paul Levitan
Community Advocate Cambridge, MA - Tieraona Low Dog, M.D.
Arizona Center for Integrative Medicine Tucson, AZ - Patrick J. Mansky, M.D.
The Cancer Team at Bellin Health Green Bay, WI - Guido F. Pauli, PharmD, Ph.D.
University of Illinois at Chicago Chicago, IL - Carl Douglas Rogers
Patient Advocate Los Angeles, CA - Xiaoming Tian, M.D., L.Ac.
Academy of Acupuncture & Chinese Medicine Bethesda, MD
|